These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 2310834)
1. Bone marrow graft engineering by counterflow centrifugal elutriation: results of a phase I-II clinical trial. Wagner JE; Santos GW; Noga SJ; Rowley SD; Davis J; Vogelsang GB; Farmer ER; Zehnbauer BA; Saral R; Donnenberg AD Blood; 1990 Mar; 75(6):1370-7. PubMed ID: 2310834 [TBL] [Abstract][Full Text] [Related]
2. Lymphocyte depletion of donor bone marrow by counterflow centrifugal elutriation: results of a phase I clinical trial. Wagner JE; Donnenberg AD; Noga SJ; Cremo CA; Gao IK; Yin HJ; Vogelsang GB; Rowley S; Saral R; Santos GW Blood; 1988 Oct; 72(4):1168-76. PubMed ID: 3048436 [TBL] [Abstract][Full Text] [Related]
3. The use of counterflow centrifugal elutriation for the depletion of T cells from unrelated donor bone marrow. Neudorf SM; Rybka W; Ball E; Blatt J; Bloom E; Corey S; deMagalhaes-Silverman M; Koehler M; Lister J; Mierski J; Mirro J; Pincus S; Wilson J; Wollman M; Donnenberg AD J Hematother; 1997 Aug; 6(4):351-9. PubMed ID: 9377073 [TBL] [Abstract][Full Text] [Related]
4. Using elutriation to engineer bone marrow allografts. Noga SJ; Wagner JE; Rowley SD; Davis JM; Vogelsang GB; Hess AD; Saral R; Santos GW; Donnenberg AD Prog Clin Biol Res; 1990; 333():345-59; discussion 360-1. PubMed ID: 2137932 [TBL] [Abstract][Full Text] [Related]
5. CD34+ stem cell augmentation of elutriated allogeneic bone marrow grafts: results of a phase II clinical trial of engraftment and graft-versus-host disease prophylaxis in high-risk hematologic malignancies. O'Donnell PV; Jones RJ; Vogelsang GB; Seber A; Ambinder RF; Flinn I; Miller C; Marcellus DC; Griffin C; Abrams R; Braine HG; Grever M; Hess AD; Piantadosi S; Noga SJ Bone Marrow Transplant; 1998 Nov; 22(10):947-55. PubMed ID: 9849691 [TBL] [Abstract][Full Text] [Related]
6. Prevention of graft-versus-host disease by lymphocyte depletion of the bone marrow graft with use of counterflow centrifugation. Haanen C; De Witte T; Plas A; Schattemberg T Haematologica; 1991 Mar; 76 Suppl 1():22-8. PubMed ID: 1864551 [TBL] [Abstract][Full Text] [Related]
7. Depletion of donor lymphocytes by counterflow centrifugation successfully prevents acute graft-versus-host disease in matched allogeneic marrow transplantation. de Witte T; Hoogenhout J; de Pauw B; Holdrinet R; Janssen J; Wessels J; van Daal W; Hustinx T; Haanen C Blood; 1986 May; 67(5):1302-8. PubMed ID: 3516253 [TBL] [Abstract][Full Text] [Related]
8. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors. Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736 [TBL] [Abstract][Full Text] [Related]
9. Effectiveness of rotor off fraction in allogeneic murine bone marrow transplantation with complete disparity of major histocompatibility. Jeong DC; Han CW; Jin JY; Kim DS; Choi IB; Kim WI; Kim HK; Kim CC; Lee BC; Imamura M; Noga SJ Exp Hematol; 1999 Jul; 27(7):1219-25. PubMed ID: 10390198 [TBL] [Abstract][Full Text] [Related]
10. T-cell depletion plus salvage immunotherapy with donor leukocyte infusions as a strategy to treat chronic-phase chronic myelogenous leukemia patients undergoing HLA-identical sibling marrow transplantation. Drobyski WR; Hessner MJ; Klein JP; Kabler-Babbitt C; Vesole DH; Margolis DA; Keever-Taylor CA Blood; 1999 Jul; 94(2):434-41. PubMed ID: 10397710 [TBL] [Abstract][Full Text] [Related]
11. Counterflow centrifugation allows addition of appropriate numbers of T cells to allogeneic marrow and blood stem cell grafts to prevent severe GVHD without substantial loss of mature and immature progenitor cells. Preijers FW; van Hennik PB; Schattenberg A; Ruijs P; Ploemacher RE; de Witte T Bone Marrow Transplant; 1999 May; 23(10):1061-70. PubMed ID: 10373074 [TBL] [Abstract][Full Text] [Related]
12. Toxicity and efficacy of defined doses of CD4(+) donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant. Alyea EP; Soiffer RJ; Canning C; Neuberg D; Schlossman R; Pickett C; Collins H; Wang Y; Anderson KC; Ritz J Blood; 1998 May; 91(10):3671-80. PubMed ID: 9573003 [TBL] [Abstract][Full Text] [Related]
13. Allogeneic bone marrow transplantation for leukemia with marrow grafts depleted of lymphocytes by counterflow centrifugation. Schattenberg A; De Witte T; Preijers F; Raemaekers J; Muus P; Van der Lely N; Boezeman J; Wessels J; Van Dijk B; Hoogenhout J Blood; 1990 Mar; 75(6):1356-63. PubMed ID: 2310832 [TBL] [Abstract][Full Text] [Related]
14. Comparison of outcome of allogeneic bone marrow transplantation with and without granulocyte colony-stimulating factor (lenograstim) donor-marrow priming in patients with chronic myelogenous leukemia. Ji SQ; Chen HR; Wang HX; Yan HM; Pan SP; Xun CQ Biol Blood Marrow Transplant; 2002; 8(5):261-7. PubMed ID: 12064363 [TBL] [Abstract][Full Text] [Related]
15. Allogeneic bone marrow transplantation for leukemia with marrow grafts treated by counterflow centrifugation. De Witte T; Schattenberg A; Preijers F; Raymakers R; Muus P; Wessels J Bone Marrow Transplant; 1993; 12 Suppl 3():S2-6. PubMed ID: 8124252 [TBL] [Abstract][Full Text] [Related]
16. Separation of rat bone marrow cells by counterflow centrifugal elutriation: a model for studying the effects of lymphocyte depletion. Wagner JE; Donnenberg AD; Noga SJ; Wiley JM; Yeager AM; Vogelsang GB; Hess AD; Santos GW Exp Hematol; 1988 Mar; 16(3):206-12. PubMed ID: 3257446 [TBL] [Abstract][Full Text] [Related]
17. [CD25 monoclonal antibody for GVHD prophylaxis in non-T-cell depleted haploidentical bone marrow transplantation for treatment of childhood leukemia]. Chen HR; Ji SQ; Yan HM; Wang HX; Liu J; Xue M; Zhu L Zhonghua Er Ke Za Zhi; 2004 Apr; 42(4):294-8. PubMed ID: 15157394 [TBL] [Abstract][Full Text] [Related]
18. Prevention of graft-versus-host disease by selective depletion of CD6-positive T lymphocytes from donor bone marrow. Soiffer RJ; Murray C; Mauch P; Anderson KC; Freedman AS; Rabinowe SN; Takvorian T; Robertson MJ; Spector N; Gonin R J Clin Oncol; 1992 Jul; 10(7):1191-200. PubMed ID: 1607923 [TBL] [Abstract][Full Text] [Related]
19. The effect of G-CSF-stimulated donor marrow on engraftment and incidence of graft-versus-host disease in allogeneic bone marrow transplantation. Ji SQ; Chen HR; Xun CQ; Wang HX; Pan SP; Xiao MH Clin Transplant; 2001 Oct; 15(5):317-23. PubMed ID: 11678957 [TBL] [Abstract][Full Text] [Related]
20. Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome. Peters C; Balthazor M; Shapiro EG; King RJ; Kollman C; Hegland JD; Henslee-Downey J; Trigg ME; Cowan MJ; Sanders J; Bunin N; Weinstein H; Lenarsky C; Falk P; Harris R; Bowen T; Williams TE; Grayson GH; Warkentin P; Sender L; Cool VA; Crittenden M; Packman S; Kaplan P; Lockman LA; Anderson J; Krivit W; Dusenbery K; Wagner J Blood; 1996 Jun; 87(11):4894-902. PubMed ID: 8639864 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]